Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 295

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 295
---
   0.00 |
| EBITDA                         |     | (10.48 | ) |     | (9.71 | ) |     | 21.31 |     | 109.51 |     | 210.23 |     | 349.29 |     | 485.71 |   |     | 574.76 |   |     | 627.58 |     | 658.96 |
| Capital Expenditure            |     |   0.00 |   |     |  0.00 |   |     |  0.00 |     |   0.00 |     |   0.00 |     |   0.00 |     |   0.00 |   |     |   0.00 |   |     |   0.00 |     |   0.00 |
| Net Cash Flow                  |     | (10.48 | ) |     | (9.71 | ) |     | 21.31 |     | 109.51 |     | 210.23 |     | 349.29 |     | 485.71 |   |     | 574.76 |   |     | 627.58 |     | 658.96 |

146

The table below identities the projected revenue for Lumee Oxygen and Lumee Glucose revenue:

| Revenue ($ in Millions) |     | 2025E |   |     | 2026E |       |     | 2027E |       |   |     | 2028E |        |   |     | 2029E |        |   |     | 2030E |        |   |     | 2031E |        |   |     | 2032E |        |   |     | 2033E |        |   |     | 2034E |        |   |
|:------------------------|:----|:------|:--|:----|:------|------:|:----|:------|------:|:--|:----|:------|-------:|:--|:----|:------|-------:|:--|:----|:------|-------:|:--|:----|:------|-------:|:--|:----|:------|-------:|:--|:----|:------|-------:|:--|:----|